Few patients with prostate cancer are willing to be randomised to treatmentBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7197.1556a (Published 05 June 1999) Cite this as: BMJ 1999;318:1556
View Full Text
- Paddy O'Reilly, Consultant urologist. (firstname.lastname@example.org),
- Linda Martin, Specialist urological nurse.,
- Gerald Collins, Consultant urological surgeon.
- on behalf of the CRASH Oncology Group, Stepping Hill Urology, Stepping Hill Hospital, Stockport SK2 7JE
EDITOR—No one would deny the need for controlled prospective trials to determine best management in serious conditions such as prostate cancer. But to adopt a nihilistic approach towards available treatments because such data do not exist is to turn back the clock of progress. Proponents of evidence based medicine may claim that there is no evidence that radical …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.